RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $404,394 | -81.0% | 32,197 | -75.1% | 0.18% | -89.3% |
| Q1 2023 | $2,128,665 | -19.3% | 129,245 | -26.8% | 1.73% | +10.7% |
| Q4 2022 | $2,637,224 | -29.6% | 176,521 | +5.5% | 1.57% | -26.8% |
| Q3 2022 | $3,744,000 | +97.3% | 167,383 | +47.7% | 2.14% | +86.6% |
| Q2 2022 | $1,898,000 | -7.5% | 113,313 | +65.2% | 1.15% | -12.2% |
| Q1 2022 | $2,053,000 | +45.4% | 68,608 | +49.2% | 1.30% | +16.1% |
| Q4 2021 | $1,412,000 | +18.7% | 45,992 | +21.9% | 1.12% | +42.8% |
| Q3 2021 | $1,190,000 | +39.8% | 37,743 | +62.3% | 0.79% | +30.3% |
| Q2 2021 | $851,000 | +46.0% | 23,250 | +37.8% | 0.60% | +39.5% |
| Q1 2021 | $583,000 | -6.3% | 16,876 | +12.7% | 0.43% | +9.1% |
| Q4 2020 | $622,000 | – | 14,975 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |